Skip navigation

 Login or Register | Member Centre

Posted AT 9:23 AM EST on 16/07/08

Abbott shares jump as profit tops forecast

Reuters

NEW YORK — Abbott Laboratories Inc. Wednesday said second-quarter earnings jumped 34 per cent, beating its expectations, fuelled by sizzling sales of its medical devices, Humira arthritis treatment and other drugs. The suburban Chicago drug maker, whose shares rose 2.5 per cent, said it earned $1.32-billion (U.S.), or 85 cents per share. That compared with $989-million, or 63 cents per share, in the year-ago quarter.

The full text of this article has 267 words.

To continue reading this article, you will need to purchase this article.

Already have a member account? Login now

Pay-Per-View Offers To read the complete article, select one of the following options

Purchasing from globeandmail.com is quick and secure.

Single Article: $4.95

4-pack: $17.95

Back to top